Elise Chapiro

20PUBLICATIONS
51CO-AUTHORS
Molecular targetsHaematological tumoursMedical mycologyMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jan 07, 2026
Olaparib sensitizes chronic lymphocytic leukemia to BTK- and BCL2-targeted therapies via PARP1-independent mitochondrial metabolic dysfunction.

Marianne Ayoub, Casilda Hitier, Léa Dehgane

|Dec 09, 2025
REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic Leukemia.

Léa Dehgane, Eliane Mallet, Constance Brasseur

|May 23, 2025
Phenotypic Profile of Waldenström Macroglobulinaemia B-Cells: Establishment of a Diagnosis Scoring System and Clinico-Biological Correlations.

|Oct 29, 2024
Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes.

Stella Charalampopoulou, Elise Chapiro, Ferran Nadeu

|May 31, 2024
Molecular landscape of mature B-cell lymphoproliferative disorders with BCL3-translocation: A Groupe Francophone de Cytogénétique Hématologique (GFCH)/French Innovative Leukemia Organization (FILO) study.

Lauren Véronèse, Hedi Bensaber, Louis-Thomas Dannus

|Apr 13, 2024
The t(X;20)(q13;q13) translocation is a good prognostic factor in myeloid neoplasms: A report of 25 cases from the Groupe Francophone de Cytogénétique Hématologique.

Florence Nguyen-Khac, Marc Muller, Elise Chapiro

Pageof 4

Frequent Collaborators

11 joint publications

Florence Nguyen-Khac

8 joint publications

Damien Roos-Weil

5 joint publications

Santos A Susin

4 joint publications

Karim Maloum